ResMed (RMD) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.42 +0.07%
EPS Growth %: +5.5%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.5%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $0.69, $0.03 better than the analyst estimate of $0.66. Revenue for the quarter came in at $454.5 million versus the consensus estimate of $446.25 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- ResMed (RMD) call put ratio 1.5 calls to 1 put as share price up 4.3%
- Could Affirm be a $200 stock?
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
